


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
LH
Laboratory Corporati
$259.75
Strengths

Earnings are forecast to grow
LH Price Performance
$264.18 (-1.68%)
$291.47 (-10.88%)
$278.18 (-6.63%)
$249.86 (+3.96%)
LH has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

LH overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Revenue increase YoY
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
LH Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
LH Street Sentiment is extremely bullish and have positive views on the near-term outlook
EXAS
102.51
+0.25%
DGX
186.06
+3.20%
HUM
277.10
+1.18%
GH
107.15
+0.24%
LH
Laboratory Corporati
259.75
+2.26%
HDB
HDFC Bank Limited
32.90
-0.96%
MDT
Medtronic
97.92
+1.57%
IMPP
Imperial Petroleum
3.99
+2.84%
MAN
ManpowerGroup
30.37
+2.64%
What is LH current stock price?
What are LH stock strengths?
What is LH Risk Level?
What is LH market cap and volume?
What is LH current Stock IQ?
Should I buy LH stock right now?
Is LH a Strong Buy right now?
What does a 'Strong Buy' rating mean for LH?
What does a 'Strong Sell' rating mean for LH?
What factors influence LH's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
LH
Laboratory Corporati
Current Price
$259.75
LH Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow
Linked to LH
EXAS
102.51
+0.25%
DGX
186.06
+3.20%
HUM
277.10
+1.18%
GH
107.15
+0.24%
Recently Viewed
LH
Laboratory Corporati
259.75
+2.26%
HDB
HDFC Bank Limited
32.90
-0.96%
MDT
Medtronic
97.92
+1.57%
IMPP
Imperial Petroleum
3.99
+2.84%
MAN
ManpowerGroup
30.37
+2.64%

LH Price Performance
$264.18 (-1.68%)
$291.47 (-10.88%)
$278.18 (-6.63%)
$249.86 (+3.96%)
LH Analysts Opinion
LH Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Revenue increase YoY
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
LH Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
LH Street Sentiment is extremely bullish and have positive views on the near-term outlook
LH has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

LH Latest Analysis
UPDATE ON CASE LAKE AS FIELD PROGRAMS RESUME. Major HighlightsGroundwater well drilling completed and surface hydrology analysis ongoing at West Joe dykeEnvironmental geochemistry sampling program completed Biological field studies program completed Ongoing engagement with the Ontario Ministry to fast track permitting".Power Metals". or the ".Company".) (TSXV:) (FRANKFURT: OAA1) (OTCQB:) is pleased to provide an update on activities underway at the Company'.s Case Lake Project (
Today
Labcorp Declares Quarterly Dividend. (NYSE:) a global leader of innovative and comprehensive laboratory services announced today that its Board of Directors has declared a cash dividend of ...
Today
YDES: YD Bio is an integrated biotechnology company that is poised to have a transformational year as it expands business operations.. By YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics precision medicine and regenerative ophthalmology under a single commercial and development strategy. The companys mission centers on early cancer detection using blood-based diagnostic tests the development of exosome-based therapeutics and tools for ophthalmic conditions an
Tue Jan 13, 2026
Thermo Fisher Scientific And NVIDIA Partner To Advance AI-Powered Laboratory Automation . (RTTNews) - Thermo Fisher Scientific Inc. (TMO) announced a strategic collaboration with NVIDIA to accelerate the adoption of AI-based solutions and laboratory automation at scale. By combining Thermo Fishers expertise in scientific instruments and lab software with NVIDIAs adv
Tue Jan 13, 2026
ARWR: Encouraging Early Data for Obesity Programs. By Business UpdateEncouraging Early Data for Obesity ProgramsOn January 6 2026 Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) announced preliminary results for the companys investigational treatments for obesity ARO-INHBE and ARO-ALK7. The company also held a webinar to discuss the results. The slides and the webinar can be accessed here. The data showed that ARO-INHBE both as a monotherapy and in combination with tirzepatide led to reductions in
Wed Jan 7, 2026
YDES is A Biotechnology Company on the Move. By YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics precision medicine and regenerative ophthalmology under a single commercial and development strategy. The companys mission centers on early cancer detection using blood-based diagnostic tests the development of exosome-based therapeutics and tools for ophthalmic conditions and infrastructure to support translational clinical work and manufacturing. Over the past y
Wed Jan 7, 2026
Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference. BURLINGTON N.C. Dec. 30 2025 /PRNewswire/ -- Labcorp (NYSE: LH) a global leader of innovative and comprehensive laboratory services announced today that the company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday Jan. 13 at 4:30 p....
Tue Dec 30, 2025
CCTV: China-Lao Agricultural Science Cooperation Delivers New Results in 2025. BEIJING Dec. 29 2025 /PRNewswire/ -- China and Lao PDR have stepped up their cooperation on agricultural science and technology with 2025 marking a year of concrete progress from laboratory planning to field-level impact. At the heart of this collaboration is the China-Lao Joint...
Mon Dec 29, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.